这类抗体中和效价测定，要用培养的“活病毒”，和分离的抗血清。以往，病毒从病人身上分离、培养，不是合成的。方法见内

https://www.biomart.cn/experiment/3324.htm

 

所有跟帖： 

• I don't see much difference. It's a very routine procedure. -twoboys_mom- ♀ (0 bytes) () 01/28/2021 postreply 08:18:15

• 关键在“合成制造病毒”，会不会造出超级病毒。这属于监管程序。临床上测抗体中和，应该使用来自病人的毒株 -fuz- ♂ (0 bytes) () 01/28/2021 postreply 08:44:27

• I see your point. We are living in a risky world. Double sword. -twoboys_mom- ♀ (0 bytes) () 01/28/2021 postreply 08:47:36